Retaining the potency of psilocybin mushrooms (aka magic mushrooms) would be a primary concern for commercial growers when the day comes that legislation approves them for cultivation, possession, sale, and use in various therapies. Scientists have known for years that the potency of these mushrooms rests primarily on the levels of psilocybin (a prodrug of psilocin) in the mushroom tissues.


Previous articleAwakn Life Sciences Begins Trading on the OTCQB(R) Venture Market Under the Symbol ‘AWKNF’ on August 12th
Next articleFilament Health Announces Q2 2021 Financial Results